Adenocarcinoma of the Esophagus
📧 Sign up to get email alerts when something new happens for Adenocarcinoma of the Esophagus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction [Phase 2]
Phase 2 trial evaluating total neoadjuvant therapy for lymph node–positive adenocarcinoma of the esophagus and esophagogastric junction is c…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer [Phase 2]
Phase 2 trial evaluating IMAB362 (zolbetuximab) in combination with the EOX chemotherapy regimen for CLDN18.2-positive gastric, gastroesopha…
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: Preoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ Adenocarcinoma [Phase 2, Phase 3]
This clinical trial update describes the completion of Phase 2 and Phase 3 trials comparing preoperative chemotherapy versus preoperative ch…
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus [Phase 2]
Phase 2 trial update on antineoplaston therapy for esophageal adenocarcinoma; study terminated with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol. [Phase 2]
Phase II clinical trial protocol assessing palliative short-course hypofractionated radiotherapy followed by chemotherapy for adenocarcinoma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Lapatinib With Carboplatin and Paclitaxel in Esophagus and Gastroesophageal Junction (GEJ) [Phase 1, Phase 2]
Phase 1/2 trial evaluating lapatinib with carboplatin and paclitaxel in esophagus and GEJ adenocarcinoma; study terminated with results post…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction [Phase 1]
This Phase 1 trial evaluates a multimodal approach using oxaliplatin, fluorouracil, and erlotinib with pre-surgical radiation, followed by a…
-
CLINICAL_TRIALS trial_result · 2017-12-27Clinical Trial Update: Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery [Phase 2]
Phase 2 pilot trial of CRLX101 for advanced/metastatic stomach, gastroesophageal junction, or esophageal cancers that are unresectable; tria…
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating everolimus in combination with chemotherapy for metastatic stomach or esophageal cancer; res…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy [Phase 2]
This Phase 2 trial investigated the combination of pralatrexate and docetaxel in patients with Stage IV esophageal or gastroesophageal cance…
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer [Phase 1, Phase 2]
Phase I/II study of oblimersen with cisplatin and fluorouracil in gastric and esophageal cancers; the trial was terminated with results post…
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer [Phase 2]
Phase 2 trial evaluating OncoGel added to chemotherapy and radiation before surgery in esophageal cancer; the study is terminated with poste…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction [Phase 2]
This update reports the completion of a Phase 2 trial evaluating 3-AP (Triapine) plus cisplatin in patients with recurrent or metastatic ade…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer [Phase 2]
A Phase II trial evaluating erlotinib hydrochloride in patients with advanced esophageal cancer and gastroesophageal junction cancer has com…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction [Phase 2]
A Phase 2 trial tested arsenic trioxide in advanced esophageal and gastroesophageal junction cancers. The study was terminated.
-
CLINICAL_TRIALS trial_result · 2009-04-28Clinical Trial Update: Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus [Phase 2]
Phase 2 trial evaluating doxorubicin, cisplatin, and 5-fluorouracil in patients with advanced adenocarcinoma of the stomach, gastroesophagea…